Clinical trials
Cerebral Hemorrhage trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Unknown status | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 3 |
| University of Erlangen-Nürnberg Medical School | 3 |
| Heidelberg University | 2 |
| Joseph Broderick, MD | 2 |
| Bielefeld University | 1 |
| C. R. Bard | 1 |
| CellMed AG, a subsidiary of BTG plc. | 1 |
| Charite University, Berlin, Germany | 1 |
| Daniel Hanley | 1 |
| Imperial College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebral Hemorrhage | 27 |
| Stroke | 8 |
| Ischemic Stroke | 7 |
| Subarachnoid Hemorrhage | 6 |
| Intracranial Hemorrhages | 3 |
| Brain Injuries, Traumatic | 2 |
| Cardiovascular Diseases | 2 |
| Cerebral Infarction | 2 |
| Cerebrovascular Disorders | 2 |
| Vascular Diseases | 2 |
Trials
Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.